Scopolamine (Hyoscine) Transdermal Patches bulk supplier for pharma manufacturers

Scopolamine (Hyoscine) Transdermal Patches 1.5 mg Suppliers & Bulk Manufacturers

Available Forms: Transdermal patch

Available Strengths: 1.5 mg

Reference Brands: Transderm-Scop(US)

Scopolamine (hyoscine) transdermal patches prevent nausea and vomiting from motion sickness and after anaesthesia. One 1.5 mg patch is placed behind the ear and works for up to three days. Reference brands are Transderm-Scop (US) and Scopoderm (Europe). Dry mouth and drowsiness are common side effects. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Scopolamine (Hyoscine) Transdermal Patches? List it or send an offer →

Product Description:

Scopolamine patches, marketed as Transderm-Scop in the US and Scopoderm in the EU, are approved for preventing nausea and motion sickness. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. Proper adherence supports timely approval, safe use, and worldwide availability, helping patients manage nausea and motion sickness effectively across healthcare regions globally.

Scopolamine (Hyoscine) Transdermal Patches — third party manufacturing & bulk supply

Scopolamine (Hyoscine) Transdermal Patches 1.5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Scopolamine (Hyoscine) Transdermal Patches is supplied as Transdermal patch — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Scopolamine (Hyoscine) Transdermal Patches listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Scopolamine (Hyoscine) Transdermal Patch... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

One patch releases about 1 mg of scopolamine over three days. For motion sickness it is applied behind the ear at least 4 hours before travel.

Generic transdermal scopolamine is approved in the US, but there are few manufacturers worldwide, so supply can be tight.

Touching the eyes after handling the patch, because it can widen the pupil. It is used with care in older people, in glaucoma and in urinary retention.